Aurobindo Pharma USA Receives FTC Approval for $250 Million Lannett Acquisition MM Desk 23 June, 2026 Aurobindo Pharma USA, Inc, a wholly owned subsidiary of Aurobindo Pharma Limited, has received approval Read More